RP
Regeneron Pharmaceuticals, Inc.
🇬🇧XLON.0R2MUnited KingdomHealthcare
$776.97USDdown -1.71 (-0.22%)ClosedEnd of day7:12 PM
Price$776.97-1.71 (-0.22%)
Profile
- Healthcare
- Biotechnology
- United Kingdom
Identity
- Exchange
- London Stock Exchange . XLON
- Type
- Stock
- ISIN
- US75886F1075
- CUSIP
- Not reported
Company
- Employees
- 15,106
- Headquarters
- Tarrytown, Brazil
- Website
- https://www.regeneron.com
Market
- Shares outstanding
- 108M
- Market cap
- $83.94B
Highlights
- Market cap
- $84.12B
- EPS LTM
- R$41.90
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- R$14.21B
- Net income
- R$4.46B
- Gross margin
- 86.46%
- Free cash flow
- Not reported
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.